Troy Bremer, Ph.D.
CSO and Founder of PreludeDx
| 0:46 | Supportive evidence for DCISionRT |
| 2:12 | DCISionRT overview and test results |
| 4:30 | Validation data highlights |
| 7:30 | RT benefit prediction and NNT data highlight |
| 8:14 | Reclassification data highlight |
Chirag Shah, MD
- Radiation Oncologist
- Director of Clinical Research and Associate Professor
- Department of Radiation Oncology at the Cleveland Clinic
| 8:54 | Introduction |
| 9:07 | Managing DCIS and RT role in background studies |
| 12:30 | Who needs or doesn’t need RT? |
| 14:07 | Changing treatment recommendations |
| 15:51 | Applying DCISionRT in my practice |
| 17:11 | Cost effectiveness and value |
| 18:39 | Case Studies |
| 19:56 | Conclusion: Radiation oncologist’s perspectives |
Pat Whitworth, MD
- Breast Surgical Oncology Specialist
- St. Thomas Health, Ascension
- Direction of Nashville Breast Center
| 21:06 | Introduction |
| 21:24 | Impact of genomic testing in clinical practice, pre-op visit |
| 22:43 | Clinical dilemma for DCIS |
| 24:33 | DCIS tools to guide patient management, pros/cons |
| 26:54 | Surgical margins and guidelines |
| 28:53 | Genomic assays for DCIS |
| 30:58 | Identifying patients with RT benefit after BCS |
| 31:58 | Patient Discussion with DCISionRT Test Report |
| 32:50 | Clinical application and case studies |
| 36:58 | Conclusion: Surgeon’s perspectives |
| 37:41 | Decision impact PREDICT Registry |
Q and A with the Panelists
| 38:50 | How to interpret DCISionRT in context of ET? |
| 39:48 | Case study recommendation with low DCISionRT |
| 42:10 | Role of MSKCC nomogram for DCIS management? |
| 43:40 | DCISionRT protocol in own medical practices? |
| 45:35 | Role of APBI in DCIS? |
| 46:48 | Which patients are indicated for DCISionRT? |